Earum Pharmaceuticals LtdBOM 542724 Stock Report

Earum Pharmaceuticals Ltd. markets, trades, and distributes pharmaceutical formulation products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2019-07-04. The firm is primarily engaged in marketing, trading and distribution of a range of pharmaceutical formulation products, such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti-cold drugs, analgesic/ anti-pyretic & anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants and injections. The company offers a range of pharmaceutical formulation products, of which around 120 products are marketed by it under its own brand name. The company also deals in the trading of active pharmaceutical ingredients (API’s). Its products include HYGNEX+, HYGNEX+ Spray, EROLON and HYGNEX. The company carries its business operations in Indian States, such as Gujarat, Maharashtra, Chhattisgarh, Uttar Pradesh, Mizoram, Andhra Pradesh, Rajasthan and others.